Reaktion #83491
ord-1d69a2322afb43d68ded4288eb501dbd
Reaktionsgleichung
Edukte
Reagenzien
Lösungsmittel
Reaktionsbedingungen
Aufarbeitung
- 1SonstigeThe cooling bath is removed
- 2workup.ADDITIONan additional 342 mg of 2-methyl-5-fluorobenzoyl chloride in 2 ml of methylene chloride is added
- 3SonstigeThe cooling bath is removed
- 4workup.STIRRINGstirring
- 5workup.WAITcontinued for 18 hours
- 6SonstigeThe volatiles are removed in vacuo to a residue which
- 7workup.DISSOLUTIONis dissolved in 50 ml of methylene chloride
- 8Waschenwashed with 20 ml each of water, 2N citric acid, 1M sodium bicarbonate and brine
- 9TrocknenThe organic layer is dried over Na2SO4
- 10SonstigeThe filtrate is evaporated in vacuo to a residue which
- 11Sonstigeis crystallized from ethyl acetate-hexane
Vorschrift
To a stirred solution of 500 mg of 10,11-dihydro-10-(4-aminobenzoyl)-5H-pyrrolo[2,1-c][1,4]benzodiazepine in 3 ml of methylene chloride, cooled to 0° C., under argon, is added 346 μl of triethylamine followed by the addition of 340 mg of 2-methyl-5-fluorobenzoyl chloride in 2 ml of methylene chloride. The cooling bath is removed and stirring continued for 18 hours. After cooling to 0° C., an additional 342 mg of 2-methyl-5-fluorobenzoyl chloride in 2 ml of methylene chloride is added. The cooling bath is removed and stirring continued for 18 hours. The volatiles are removed in vacuo to a residue which is dissolved in 50 ml of methylene chloride and washed with 20 ml each of water, 2N citric acid, 1M sodium bicarbonate and brine. The organic layer is dried over Na2SO4 and passed through a pad of hydrous magnesium silicate. The filtrate is evaporated in vacuo to a residue which is crystallized from ethyl acetate-hexane to give 295 mg of the desired product as a white solid, m.p. 170°-180° C.